This proposal is full of ambitious language but I am left unclear about the possible clinical relevance of their approach. These trials only measured a single surrogate endpoint (HbA1c) over relatively short periods of time against a small number of comparators. At best, this can only be an exploratory methodological study of a particular approach to “personalization”.
Unsure, further clarification from requestor is needed Unsure, further clarification from requestor is neededI am skeptical about the value of this proposal and the feasibility of using the data set to achieve anything other than an exploratory foray. On the other hand, it could be argued that this a bona fide attempt which should not be dismissed.
Not Approve